3M CO (MMM) Earnings History

3M CO - Q4 FY2025 Earnings

Filed at: Jan 20, 2026, 6:34 AM EST|Read from source

EXECUTIVE SUMMARY

3M reported mixed Q4 FY2025 results with GAAP sales growth but declining GAAP EPS, while adjusted metrics showed improvement. The company is focused on building a strong foundation for sustainable value creation and expects to outperform the macro environment in 2026.

POSITIVE HIGHLIGHTS

  • •

    Adjusted EPS of $1.83, up 9% year-on-year for Q4.

    positive
  • •

    Adjusted operating income margin of 21.1%, an increase of 140 basis points year-on-year for Q4.

    positive
  • •

    Full-year adjusted EPS of $8.06, up 10% year-on-year.

    positive
  • •

    Full-year adjusted operating income margin of 23.4%, an increase of 200 basis points year-on-year.

    positive
  • •

    Full-year 2026 guidance includes adjusted total sales growth of ~4% and adjusted EPS in the range of $8.50 to $8.70.

    positive

CONCERNS & RISKS

  • •

    Q4 GAAP EPS of $1.07, down 20% year-on-year.

    negative
  • •

    Q4 GAAP operating margin of 13.0%, down 510 basis points year-on-year.

    negative
  • •

    Full-year GAAP EPS of $6.00, down 17% year-on-year.

    negative
  • •

    Full-year GAAP operating margin of 18.6%, down 100 basis points year-on-year.

    negative
  • •

    Q4 organic sales growth was only 0.6% year-on-year, with declines in Consumer and Transportation and Electronics segments.

    attention

FINANCIAL METRICS

Revenue
Quarterly
$6.13B
+2.1%
Prior year: $6.01B
Annual (YTD)
$24.95B
N/A
Prior year: $24.57B
Net Income
Quarterly
$577.00M
-20.7%
Prior year: $728.00M
Annual (YTD)
$3.25B
N/A
Prior year: $4.17B
EPS (Diluted)
Quarterly
$1.07
-19.6%
Prior year: $1.33
Annual (YTD)
$6.00
N/A
Prior year: $7.55
Operating Income
Quarterly
$796.00M
-26.6%
Prior year: $1.08B
Annual (YTD)
$4.63B
N/A
Prior year: $4.82B
EPS (Basic)
Quarterly
$1.08
-19.4%
Prior year: $1.34
Annual (YTD)
$6.05
N/A
Prior year: $7.58

MARGIN ANALYSIS

Operating Margin
Current Quarter
13.0%
Prior Year
18.1%
YoY Change
-510 bps
Net Margin
Current Quarter
9.4%
Prior Year
12.1%
YoY Change
-270 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

REVENUE BY SEGMENT — Q4 FY2025 2025

VISUAL OVERVIEW

|
Safety and Industrial
47.4%
$2865000.0B
(+6.0% YoY)
Prior year: $2703000.0B
Transportation and Electronics
32.5%
$1961000.0B
(-1.7% YoY)
Prior year: $1994000.0B
Consumer
20.1%
$1214000.0B
(-1.2% YoY)
Prior year: $1229000.0B

DETAILED BREAKDOWN

|
SegmentCurrentPrior YrYoY% Total
Safety and Industrial
$2865000.0B$2703000.0B+6.0%47.4%
Transportation and Electronics
$1961000.0B$1994000.0B-1.7%32.5%
Consumer
$1214000.0B$1229000.0B-1.2%20.1%
Total Revenue$6040000.0B——100.0%

Segment performance shows business unit health and growth drivers.

MANAGEMENT GUIDANCE

FY 2026

adjusted_total_sales_growth
$4.0M
"~4 percent"
adjusted_organic_sales_growth
$3.0M
"~3 percent"
adjusted_operating_income_margin_expansion
70.0%—80.0%
Mid-point: 75.0%
"70 bps to 80 bps"
adjusted_eps
$8.50—$8.70
Mid-point: $8.60
"In the range of $8.50 to $8.70"
adjusted_operating_cash_flow
5,600,000,000—5,800,000,000
Mid-point: 5,700,000,000
"$5.6 to $5.8 billion"

Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.

SPECIAL ITEMS & ADJUSTMENTS

Q4 2025
Net costs for significant litigation
Impact on comparability and interpretation
$0.56 per share
Q4 2025
Decrease in value of Solventum ownership
Impact on comparability and interpretation
$0.30 per share
Q4 2025
Manufactured PFAS products
Impact on comparability and interpretation
$0.39 per share
Q4 2025
Transformation costs
Impact on comparability and interpretation
$0.11 per share
Q4 2024
Net costs for significant litigation
Impact on comparability and interpretation
$0.07 per share
Q4 2024
Increase in value of Solventum ownership
Impact on comparability and interpretation
$0.24 per share
Q4 2024
Pension risk transfer charge
Impact on comparability and interpretation
$0.02 per share
Q4 2024
Manufactured PFAS products
Impact on comparability and interpretation
$0.16 per share
FY 2025
Net costs for significant litigation
Impact on comparability and interpretation
$1.95 per share
FY 2025
Decrease in value of Solventum ownership
Impact on comparability and interpretation
$0.78 per share
FY 2025
Manufactured PFAS products
Impact on comparability and interpretation
$0.47 per share
FY 2025
Loss on business divestitures
Impact on comparability and interpretation
$0.29 per share
FY 2025
Transformation costs
Impact on comparability and interpretation
$0.13 per share
FY 2024
Net costs for significant litigation
Impact on comparability and interpretation
$1.32 per share
FY 2024
Increase in value of Solventum ownership
Impact on comparability and interpretation
$2.83 per share
FY 2024
Pension risk transfer charge
Impact on comparability and interpretation
$1.11 per share
FY 2024
Manufactured PFAS products
Impact on comparability and interpretation
$0.20 per share
FY 2024
Divestiture costs
Impact on comparability and interpretation
$0.24 per share
Total Impact
$3.21 per share

Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.

MANAGEMENT COMMENTARY

2025 was an important year for 3M as we build a strong foundation that is reshaping our operating model and driving sustainable value creation.

— 3M CO, Q4 FY2025 2025 Earnings Call

Finished 2025 with growth above macro, strong margin expansion, double-digit earnings growth, and solid cash conversion.

— 3M CO, Q4 FY2025 2025 Earnings Call

Our accelerated pace of innovation and commercial execution positions us to outperform the macro environment again in 2026.

— 3M CO, Q4 FY2025 2025 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

Related Research

Research

PFAS Forever Chemicals: What 736 SEC Filings Reveal

Analysis

NTRA 10-K Analysis: The $135M Revenue Catch-Up Behind Natera's 36% Growth

Analysis

MMM 10-K Analysis: Why 3M Reports Two Different Companies in One Filing